src: ajplung.physiology.org
Fluticasone furoate is a synthetic corticosteroid derived from fluticasone, marketed by GlaxoSmithKline as Veramyst and Flonase Sensimist (US), Allermist (Japan, ?????) and Avamys (Australia, Canada, EU, South Africa, South America, Mexico, Israel, and South Korea) for the treatment of allergic rhinitis administered by a nasal spray.
The combination drug fluticasone furoate/vilanterol, marketed as Breo Ellipta (US, Canada) and Relvar Ellipta (UK), is approved for use in the United States by the Food and Drug Administration for long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. As of 2015, it is also approved for the treatment of asthma.
Video Fluticasone furoate
See also
- Fluticasone
- Fluticasone furoate/vilanterol
- Fluticasone propionate
- Fluticasone propionate/salmeterol
Maps Fluticasone furoate
References
Source of the article : Wikipedia
0 Comments